Healthcare/biotech funds ended the year with net inflows of $1.7 billion, even though $755 million exited these funds in 4Q12. The NYSE Healthcare Index was unchanged in 4Q12, but was up 12% for the year. The BioCentury 100 Index was down 4% last quarter, but was up 26% for 2012. December fund flows figure is provisional. Source: EPFR Global